Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.360SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.360EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.360EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.360NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.360NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.578ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XBB.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.18.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
FL.18.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
FL.18.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FL.18.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
FL.18.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.18.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.18.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.18.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.15ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
FL.15ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
FL.15SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FL.15SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
FL.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
EG.14ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
EG.14ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
EG.14SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
EG.14SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
EG.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.14ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
FL.14ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
FL.14SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FL.14SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
FL.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.3.12ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XBB.2.3.12ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.2.3.12SWon-SCTACATGCACCAGCAACTGT20502311423133F-17500.9South Korea
XBB.2.3.12SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBB.2.3.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.23.2.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
FL.23.2.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used